Anorexiants Market Size, Share, Growth, Trends, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Anorexiants Market covers analysis By Drug Classification (Catecholamines Anorexiants, Serotonin Anorexiants); Route of Administration (Oral, Subcutaneous); Distribution Channel (Institutional sales, Hospitals and Clinics, Retail sales, Online pharmacies, Mail Order Pharmacies) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00008552
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

MARKET OVERVIEW



Anorexiants is also termed appetite-suppressing drugs is a medication therapeutically developed to help in the management of obesity. This medication works by acting on the brain to suppress appetite and hence results in lower food consumption. Obesity is a chronic condition, in which excess body fat is accumulated to such an extent that it could have negative effects on the health of the individual. It occurs over time when people eat more calories than they utilize.

MARKET SCOPE



The "Global Anorexiants Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Anorexiants market with detailed market segmentation by drug class, route of administration, distribution channel and geography. The report provides key statistics on the market status of the leading Anorexiants market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  •   Based on drug class, the global Anorexiants market is segmented into catecholamines anorexiants, serotonin anorexiants.
  •   Based on route of administration, the market is categorised into oral, subcutaneous.
  •   Based on distribution channel, the market is categorised into institutional sales, hospitals and clinics, retail sales, online pharmacies, mail order pharmacies.

MARKET DYNAMICS


Drivers:



  •   Increase in the burden of obesity-related disorders.
  •   Rise in availability of branded drugs
  •   Rise in the sedentary lifestyle, limited physical inactivity, and poor dietary habits resulted in weight gain

Restraints:



  •   Various side effects associated with anorexiants.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Anorexiants market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Anorexiants market in these regions.

IMPACT OF COVID-19 ON ANOREXIANTS MARKET



COVID-19 lockdown has resulted in challenges for people living with obesity. As during this period, the lifestyle was deeply modified: diet, activity, and sleep behaviors, home office, take care of child, social distancing. All of these modifications may have led to stress and anxiety. It has been previously demonstrated that high perceived stress levels are correlated with high preference for sweet and fat foods. In this situation, the incidences of binge eating disorder has also increased which is characterized by compulsive overeating or consuming abnormal amounts of food while feeling unable to stop and a loss of control. Thus, patients with binge eating disorders may have been more sensitive to the impact of lockdown and thus urgently would require appropriated care management.

MARKET PLAYERS



The report covers key developments in the Anorexiants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Anorexiants market are anticipated to lucrative growth opportunities in the future with the rising demand for Anorexiants in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Anorexiants market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Akrimax Pharmaceuticals, LLC
  •   Teva Pharmaceuticals
  •   Janssen Ortho, LLC
  •   Roche Pharmaceuticals
  •   Arena Pharmaceuticals GmbH
  •   Novo Nordisk A/S
  •   Epic Pharma
  •   Patheon Pharmaceuticals Inc
  •   Catalent Pharma Solutions
  •   Recordati Rare Diseases Inc.
  •   MOVA Pharmaceuticals
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Anorexiants Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Drug Classification
  • Catecholamines Anorexiants
  • Serotonin Anorexiants
By Route of Administration
  • Oral
  • Subcutaneous
By Distribution Channel
  • Institutional sales
  • Hospitals and Clinics
  • Retail sales
  • Online pharmacies
  • Mail Order Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Akrimax Pharmaceuticals, LLC
  • Teva Pharmaceuticals
  • Janssen Ortho, LLC
  • Roche Pharmaceuticals
  • Arena Pharmaceuticals GmbH
  • Novo Nordisk A/S
  • Epic Pharma
  • Patheon Pharmaceuticals Inc
  • Catalent Pharma Solutions
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    anorexiants-market-report-deliverables-img1
    anorexiants-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    Anorexiants Market
    Connect With Expert
    The List of Companies

    1. Akrimax Pharmaceuticals, LLC
    2. Teva Pharmaceuticals
    3. Janssen Ortho, LLC
    4. Roche Pharmaceuticals
    5. Arena Pharmaceuticals GmbH
    6. Novo Nordisk A/S
    7. Epic Pharma
    8. Patheon Pharmaceuticals Inc
    9. Catalent Pharma Solutions
    10. Recordati Rare Diseases Inc
    11. MOVA Pharmaceuticals
    anorexiants-market-cagr